Report Finder

All Sentinel reports, surveillance tools, FDA assessments, and communication materials may be searched using the options below. Search results can be further sorted by title, project status, and date posted by clicking on the relevant column header. If you wish to search for FDA Center assessments more specifically by medical product and health outcome, please go to the CDER Assessments and CBER Assessments pages.

E.g., 8/18/2019
E.g., 8/18/2019
Title Status FDA Centersort ascending Date Posted
Trends in Fibroid Surgery and Use of Power Morcellation Complete CDRH 12/14/2017
Use of Stents Complete CDRH 01/23/2018
Occurrence of Selected HCPCS Codes 1 Complete CDER 08/30/2012
Incident Testosterone Indication Diagnoses and Testosterone Use Complete CDER 07/06/2016
Non-Melanoma Skin Cancer following Hydrochlorothiazide Use: A Propensity Score Matched Analysis In progress CDER 06/11/2019
Smoking Cessation Drugs and Cardiovascular Outcomes Complete CDER 01/15/2012
Activa Tremor Control Diagnoses Complete CDER 10/15/2014
Incident Use of Rivaroxaban Complete CDER 03/07/2018
Multiple Sclerosis Medication Use Complete CDER 01/08/2014
Vascular Endothelial Growth Factor (VEGF) Inhibitor Prevalent and Incident Use Complete CDER 05/09/2013
Drug Use Following Genetic Testing Among Patients with Cancer Complete CDER 05/10/2017
Occurrence of Selected Generic Drugs 4 Complete CDER 12/13/2012
Hypogonadism and Testosterone Use Complete CDER 07/06/2016
Severe Uterine Bleed following Novel Oral Anticoagulants Use: A Propensity Score Matched Analysis In progress CDER 04/18/2019
Angiotensin II Receptor Blockers and Celiac Disease Complete CDER 01/16/2012
Activa Tremor Control Procedures Complete CDER 10/16/2014
Prevalent and Incident Use of Generic Name Kinase Inhibitors In progress CDER 03/08/2018
Multiple Sclerosis Medication Injections Complete CDER 01/08/2014
Use of Ospemifene, Boceprevir, and Telaprevir In progress CDER 12/29/2017
Parkinson’s Disease Medication Use Complete CDER 06/07/2013
Golimumab, Ustekinumab, and Dronedarone Hydrochloride Use (by Quarter) Complete CDER 12/13/2012
Incident Testosterone Use Complete CDER 07/06/2016
Utilization Patterns of Obesity Drugs Complete CDER 03/19/2019
Ascension Metacarpophalangeal Diagnoses Complete CDER 10/16/2014
Incident Use of Hepatitis C Virus (HCV) Drugs In progress CDER 03/13/2018
Prevalent and Incident Use of Acetazolamide In progress CDER 01/09/2014
Incident and Prevalent Dispensings of Mirabegron In progress CDER 01/01/2018
Oxicam NSAIDs, Modafinil/Armodafinil, Sulfamothoxazole and Severe Cutaneous Adverse Reaction (SCAR) Events Complete CDER 06/07/2013
Anti-epileptic Drugs and Angioedema Complete CDER 07/17/2017
Occurrence of Selected Generic Drugs 5 Complete CDER 12/13/2012
SGLT-2 Inhibitor Use and Incidence of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus Complete CDER 03/19/2019
Serious Cutaneous Adverse Reaction (SCAR) Diagnoses Complete CDER 04/09/2012
Ascension Metacarpophalangeal Procedures Complete CDER 10/16/2014
Concomitancy and Indications for Idelalisib Use Complete CDER 03/13/2018
PROMPT: Rivaroxaban Surveillance Complete CDER 01/31/2018
Clostridium Difficile Prevalence and Vancomycin, Fidaxomicin, and Tocilizumab Use Complete CDER 01/08/2018
Angiotensin Receptor Blockers (ARBs), Hydrochlorothiazide, Atenolol, Amlodipine Use and Celiac Disease Complete CDER 06/07/2013
Actemra (Tocilizumab) Utilization Among Pregnant Women Complete CDER 07/18/2017
Natalizumab and Efalizumab Use Complete CDER 12/13/2012
Characteristics of Gout Patients and Use of Urate-Lowering Therapies Complete CDER 03/22/2019
Aseptic Necrosis of Bone Jaw Diagnoses Complete CDER 04/09/2012
CPAX Aneurysm Diagnoses Complete CDER 10/16/2014
Identifying Suicide Codes in the Sentinel Distributed Database (SDD) Complete CDER 04/24/2018
Acute Kidney Failure Diagnoses Complete CDER 01/11/2014
Use of Dronedarone HCL In progress CDER 01/08/2018
Occurrence of Selected Pediatric Drugs 1 Complete CDER 06/07/2013
Occurrence of Selected Generic Drugs 3 Complete CDER 12/13/2012
Immunoglobulin Products and Hemolysis Complete CDER 07/06/2016
Brintellix and Brilinta Medication Errors due to Name Confusion Complete CDER 03/25/2019
Progressive Multifocal Leukoencephalopathy Diagnoses Complete CDER 04/26/2012
CPAX Aneurysm Procedure Codes Complete CDER 10/21/2014
Use of Atrial Fibrillation Drugs Complete CDER 03/16/2018
Hemodialysis Procedures Complete CDER 01/12/2014
Occurrence of Selected Generic Drugs 13 Complete CDER 01/11/2018
Occurrence of Selected Generic Drugs 7 Complete CDER 07/17/2013
Golimumab, Ustekinumab, and Dronedarone Hydrochloride Use (by Year) Complete CDER 12/13/2012
New Use of Statins and Rhabdomyolysis Complete CDER 06/30/2016
Acute Myocardial Infarction and Stroke among Patients with Testosterone-Related Indications Complete CDER 03/25/2019
Hyperlipidemia Diagnoses Complete CDER 04/26/2012
Lap-band Diagnosis Codes Complete CDER 10/20/2014
Counts and Prevalence of Alendronate, Risedronate, Ibandronate, and Zolendronate Complete CDER 03/19/2018
Occurrence of Selected Dental HCPCS Codes Complete CDER 01/11/2014
Occurrence of Selected Generic Drugs 8 Complete CDER 07/17/2013
Indications of Use Among Oral Antifungal Drug Users Complete CDER 09/01/2017
Injection Ustekinumab and Injection Denosumab Procedures Complete CDER 12/13/2012
Serum Creatinine Procedures and Labs Complete CDER 06/30/2016
Dolutegravir Use During Pregnancy Complete CDER 03/28/2019
Heart/Lung Resuscitation (CPR), Injection Diphenhydramine Hydrochloride (HCL), Injection Adrenaline Epinephrine Procedures Complete CDER 04/26/2012
Procedure Codes Related to Memory Gel Breast Implants Complete CDER 11/10/2014
Counts and Prevalence of Linezolid and Vancomycin Complete CDER 03/19/2018
Nursing Home Facility HCPCS Codes Complete CDER 01/10/2014
Prevalent and Incident Use of Isotretinoin In progress CDER 01/16/2018
New Molecular Entities In progress CDER 10/04/2017
Pegylated Products Use In progress CDER 10/06/2017
Injection Natalizumab Procedures Complete CDER 12/13/2012